Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-DYNLL1 Antibody (2G523) is an antibody targeting DYNLL1. Anti-DYNLL1 Antibody (2G523) can be used in ELISA, IHC, FCM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 μL | $207 | 7-10 days | |
100 μL | $347 | 7-10 days |
Description | Antibody Type: Recombinant Rabbit Monoclonal Application: ELISA, IHC, FCM Reactivity: Human |
Alias | Protein Inhibitor of Neuronal Nitric Oxide Synthase, PIN, HDLC1, DYNLL1, Dynein Light Chain LC8-Type 1, Dynein Light Chain 1 Cytoplasmic, DNCLC1, DNCL1, DLC8, DLC1, 8 kDa Dynein Light Chain |
Ig Type | Rabbit IgG |
Clone | 2G523 |
Reactivity | Human |
Verified Activity | 1. IHC image of TMAH-00372 diluted at 1:50 and staining in paraffin-embedded human breast cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.58% DAB. 2. Overlay Peak curve showing MCF-7 cells stained with TMAH-00372 (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% TritonX-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1µg/1*10^6 cells) for 45min at 4°C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG(H+L) at 1:200 dilution for 35min at 4°C.Control antibody (green line) was rabbit IgG (1µg/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed. |
Application | ELISA, IHC, FCM |
Recommended Dose | IHC:1:50-1:200; FCM:1:50-1:200. |
Antibody Type | Monoclonal |
Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton. Nucleus. Mitochondrion. |
Construction | Recombinant Antibody |
Purification | Affinity-chromatography |
Appearance | Liquid |
Formulation | Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Research Background | Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures. Binds and inhibits the catalytic activity of neuronal nitric oxide synthase. Promotes transactivation functions of ESR1 and plays a role in the nuclear localization of ESR1. Regulates apoptotic activities of BCL2L11 by sequestering it to microtubules. Upon apoptotic stimuli the BCL2L11-DYNLL1 complex dissociates from cytoplasmic dynein and translocates to mitochondria and sequesters BCL2 thus neutralizing its antiapoptotic activity. |
Conjucates | Unconjugated |
Immunogen | A synthetic peptide: Human DYNLL1 |
Antigen Species | Human |
Gene ID | 8655 |
Uniprot ID | |
Biology Area | Epigenetics and Nuclear Signaling, Neuroscience, Cancer, Cell biology, Metabolism, Signal transduction |
Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.